Evidence map›Paper›PMID 30820179›Full record

ArticleJournal of medical biochemistry2019

Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.

Nora Alyahri, Saba Abdi, Wajahatullah Khan, Mohamed Elrobh, Mohammed H Addar, Zeneb A Babay, Mohamed Alanazi, Sooad Aldaihan, Jilani Shaik, Maha Arafah and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of medical biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nora AlyahriDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Saba AbdiDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Wajahatullah KhanDepartment of Basic Sciences, College of Science and Health Professions, King Saud Bin Abdul Aziz University for Health Sciences, Riyadh, Saudi Arabia.
Mohamed ElrobhDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohammed H AddarDepartment of Obs/Gyn, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Zeneb A BabayDepartment of Obs/Gyn, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Mohamed AlanaziDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Sooad AldaihanDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Jilani ShaikGenome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Maha ArafahDepartment of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Narasimha Reddy ParineGenome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Arjumand WarsyCentral Laboratory, Center for Science and Medical Studies for Girls, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SAKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutations in BRCA1 gene have been implicated in ovarian cancers, and BRCA testing may be conducted in high-risk women. This study was designed to determine the frequency of three single nucleotide polymorphisms (SNPs) variants in BRCA1 gene and BRCA1 expression in Saudi females with ovarian cancer.

methodsExpression levels of mRNA of BRCA1 gene were studied in 10 ovarian cancer and 10 normal ovarian tissues, by quantitative real time polymerase chain reaction (qPCR). The study also included 28 females who had suffered from ovarian cancer and had been successfully operated upon and 90 healthy females with no history of cancer. Blood was drawn in EDTA tubes and used for extraction of DNA. The genotyping was carried out using Taqman® SNP Genotyping kit by RT-PCR. The variants investigated included c.871 T>C (rs799917), c.1040 G>A (rs4986852), c.181 T>G (rs28897672) in BRCA1 gene.

resultsThe c.181 T>G (rs28897672) showed significantly different genotype and allele frequencies between the patients and the control subjects (p value = 0.002 and 0.02, respectively). The genotype TG was significantly protective (OR = 0.36, p value = 0.024). The mRNA expression of BRCA1 gene was found to be low in the ovarian cancer tissues.

conclusionsThis study showed that c.181 T>G in BRCA1 genes is associated with the development of ovarian cancer in Saudis. More studies are needed to unveil other SNPs that may be associated with ovarian cancer and to understand the mechanism(s) involved in reducing the expression of BRCA1 gene in ovarian cancer tissues.

Indexed as

BRCA1c.181 T>Govarian cancerpolymorphismSaudi Arabia

Identifiers

PMID30820179
PMCPMC6298454
OpenAlexW2898866572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.